Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases and 66% effective overall by trial data
The Johnson & Johnson Covid-19 vaccine is 66% effective in global testing, but 85% effective against serious illnesses, says the company
Live news from Coronavirus: Novavax effective against the UK variant; Emirates suspends flights to and from Britain | World News